Halogenated Flavonoid Derivatives Display Antiangiogenic Activity

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Cancer Research

Background:

• Antiangiogenic agents are crucial in cancer therapy, inhibiting tumor growth and metastasis.
• Dual-action drugs with antiproliferative and antiangiogenic activities can enhance efficacy and overcome resistance.

Purpose of the Study:

• To evaluate the antiangiogenic potential of synthetic flavones and their derivatives.
• To investigate the Structure-Activity Relationships (SAR) and identify potential molecular targets.

Main Methods:

• In vitro assays measuring endothelial cell tube formation and migration.
• Western blotting to assess VEGFR2 phosphorylation.
• In silico molecular docking studies with VEGFR2.

Main Results:

• Synthetic flavones (5a,b) and derivatives (4b, 6a) significantly inhibited endothelial cell tube formation and migration.
• Compounds 5a and 5b effectively reduced VEGFR2 phosphorylation, indicating VEGFR2 as a likely target.
• Compound 5b showed the best docking fit with VEGFR2, highlighting the importance of specific structural features.

Conclusions:

• Halogenated flavones exhibit significant antiangiogenic activity, with VEGFR2 as a probable molecular target.
• The study elucidates SAR for these compounds, identifying key structural elements for VEGFR2 interaction.
• These flavones represent promising lead compounds for developing novel antiangiogenic and anticancer therapeutics.